Northwire Canada EditionFriday, October 16, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4170.10 +1.5% SILVER 57.16 +2.3% COPPER 6.56 −1.5% OIL 97.97 +3.0% PALLADIUM 1136.00 +3.6% LUN 32.91 +0.6% DLP 0.290 −3.3% VCV 0.065 −13.3% GG 2.89 +1.4% NBLC 0.015 +0.0% SF 0.300 −4.8% ATY 0.215 +2.4% GHL 0.060 −7.7% STND 0.060 −7.7% B 0.550 −3.5% HBM 34.33 −0.5% NTR 98.77 −0.7% SGZ 0.035 +0.0% MKA 0.670 +0.0% LXM 0.175 −18.6% CLCH 1.08 −1.8% GOLD 4170.10 +1.5% SILVER 57.16 +2.3% COPPER 6.56 −1.5% OIL 97.97 +3.0% PALLADIUM 1136.00 +3.6% LUN 32.91 +0.6% DLP 0.290 −3.3% VCV 0.065 −13.3% GG 2.89 +1.4% NBLC 0.015 +0.0% SF 0.300 −4.8% ATY 0.215 +2.4% GHL 0.060 −7.7% STND 0.060 −7.7% B 0.550 −3.5% HBM 34.33 −0.5% NTR 98.77 −0.7% SGZ 0.035 +0.0% MKA 0.670 +0.0% LXM 0.175 −18.6% CLCH 1.08 −1.8%
Other

Apolo V Acquisition Corp. Announces Shareholder Approvals

By The Northwire Desk — AI Analysis Mar 06, 2026 · 09:09 AFV · 0.1
AFV · Price

Executive Summary

  • Apolo V Acquisition Corp. announced that shareholders approved all resolutions related to its proposed qualifying transaction with TelyRx, Inc., including a name change to “TelyRx Holdings Inc.” and share‑consolidation plans.
  • The election of directors received 100% approval; the share‑capital reorganization was approved by 98.6% of votes.
  • An omnibus equity incentive plan and appointment of RSM Canada LLP as auditors were also ratified, clearing key governance steps needed to complete the transaction.

Key Details

  • Election of Directors: 100% shareholder approval.
  • Name Change to “TelyRx Holdings Inc.” (or other name determined by TelyRx): 100% approval.
  • Share Consolidation Ratio: Approved range of 1 post‑consolidation share for every 20–60 pre‑consolidation shares; received 100% approval.
  • Share‑Capital Reorganization: Creation of “Subordinate Voting Shares” with special rights and a new class called “Proportionate Voting Shares”; approved by 98.6% of votes (meeting the TSXV majority‑of‑minority requirement).
  • Omnibus Equity Incentive Plan: Approved by 98.6% of shareholders, to be adopted upon completion of the Qualifying Transaction.
  • Auditor Appointment: RSM Canada LLP approved as post‑transaction auditors with 100% shareholder support.
  • Overall Voting Outcome: All resolutions passed, meeting or exceeding TSXV and TSX majority‑of‑minority thresholds.

Notable Quotes

(No direct quotes were provided in the release.)

Read the original news release →

More from

Mar 25, 2026 · 04:59

TelyRx QT Filing Clears Final Hurdles as Financing Target Slashes to $20M

Financings Feb 20, 2026 · 12:10

Apolo V Acquisition Corp. Amendment to Definitive Agreement with TelyRx, Inc. and Rescheduling of Special Meeting of Shareholders

M&A / Property Jan 21, 2026 · 16:43

Apolo V Acquisition Corp. Enters into Definitive Agreement with Telyrx, Inc.

Financings Dec 05, 2025 · 14:26

Apolo V Acquisition Corp. and TelyRx, Inc. Enter into Letter of Intent to Complete Qualifying Transaction

M&A / Property Oct 24, 2025 · 10:18

Apolo V Acquisition Corp. Completes Initial Public Offering

Financings